APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Selected research

Industry Growth & Trends

Global Human Vaccine Industry Growth and Trends Forecast to 2032

21 December 2025120 pages

Choose your research edition.

Industry ResearchHuman Vaccine Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Vaccine Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Human Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Vaccine Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.

East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.

Read the full market overview

In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.

Report Scope

This report provides a structured, data-driven view of the global Human Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Vaccine market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Vaccine Market by Company

CNBG

Changsheng Life

Zhifei

ChengDa Bio

Kangtai

SINOVAC BIOTECH

Hissen

Walvax Biotechnology

GSK

SANOFI

Rong An

NuoCheng Bio

Hualan Bio

Tiantan biological

Changchun Baike

Adimmune

Zhongyianke Biotech

Bharat Biotech

Bavarian Nordic

Sanofi-Pasteur

Indian Immunologicals

KANGH

Henan Grand Biopharma

ZhongKe Biopharm

Zhuoyi Biological

Human Vaccine Segment by Type

Varicella

Influenza

Polio

Hepatitis A

Rabies

BCG

Hepatitis B

Pertussis, Diphtheria, Tetanus

Pneumococcal

Rota vaccine

Human Vaccine Segment by Application

Adults

Children

Human Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Varicella Table 2. Major Company of Influenza Table 3. Major Company of Polio Table 4. Major Company of Hepatitis A Table 5. Major Company of Rabies Table 6. Major Company of BCG Table 7. Major Company of Hepatitis B Table 8. Major Company of Pertussis, Diphtheria, Tetanus Table 9. Major Company of Pneumococcal Table 10. Major Company of Rota vaccine Table 11. Global Human Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 12. Global Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 13. Global Human Vaccine Sales Market Share in Volume by Type (2021-2026) Table 14. Global Human Vaccine Sales by Type (2021-2026) & (US$ Million) Table 15. Global Human Vaccine Sales Market Share in Value by Type (2021-2026) Table 16. Global Human Vaccine Price by Type (2021-2026) & (USD/Dose) Table 17. Global Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 18. Global Human Vaccine Sales Market Share in Volume by Type (2027-2032) Table 19. Global Human Vaccine Sales by Type (2027-2032) & (US$ Million) Table 20. Global Human Vaccine Sales Market Share in Value by Type (2027-2032) Table 21. Global Human Vaccine Price by Type (2027-2032) & (USD/Dose) Table 22. North America Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 23. North America Human Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Europe Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 25. Europe Human Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Asia-Pacific Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 27. Asia-Pacific Human Vaccine Sales by Type (2021-2026) & (US$ Million) Table 28. Latin America Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 29. Latin America Human Vaccine Sales by Type (2021-2026) & (US$ Million) Table 30. Middle East and Africa Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 31. Middle East and Africa Human Vaccine Sales by Type (2021-2026) & (US$ Million) Table 32. Human Vaccine Industry Trends Table 33. Human Vaccine Industry Drivers Table 34. Human Vaccine Industry Opportunities and Challenges Table 35. Human Vaccine Industry Restraints Table 36. Global Human Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 37. Global Human Vaccine Revenue Market Share by Company (2021-2026) Table 38. Global Human Vaccine Sales by Company (2021-2026) & (M Doses) Table 39. Global Human Vaccine Sales Share by Company (2021-2026) Table 40. Global Human Vaccine Market Price by Company (2021-2026) & (USD/Dose) Table 41. Global Human Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 42. Global Human Vaccine Major Company Production Sites and Headquarters Table 43. Global Human Vaccine Company, Product Type & Application Table 44. Global Human Vaccine Company Establishment Date Table 45. Global Company Market Concentration Ratio (CR5 and HHI) Table 46. Global Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 47. Global Human Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 48. Global Human Vaccine Sales by Region (2021-2026) & (M Doses) Table 49. Global Human Vaccine Sales Market Share in Volume by Region (2021-2026) Table 50. Global Human Vaccine Sales by Region (2021-2026) & (US$ Million) Table 51. Global Human Vaccine Sales Market Share in Value by Region (2021-2026) Table 52. Global Human Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 53. Global Human Vaccine Sales by Region (2027-2032) & (M Doses) Table 54. Global Human Vaccine Sales Market Share in Volume by Region (2027-2032) Table 55. Global Human Vaccine Sales by Region (2027-2032) & (US$ Million) Table 56. Global Human Vaccine Sales Market Share in Value by Region (2027-2032) Table 57. Global Human Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2027-2032) Table 58. Global Human Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 59. Global Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 60. Global Human Vaccine Sales Market Share in Volume by Application (2021-2026) Table 61. Global Human Vaccine Sales by Application (2021-2026) & (US$ Million) Table 62. Global Human Vaccine Sales Market Share in Value by Application (2021-2026) Table 63. Global Human Vaccine Price by Application (2021-2026) & (USD/Dose) Table 64. Global Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 65. Global Human Vaccine Sales Market Share in Volume by Application (2027-2032) Table 66. Global Human Vaccine Sales by Application (2027-2032) & (US$ Million) Table 67. Global Human Vaccine Sales Market Share in Value by Application (2027-2032) Table 68. Global Human Vaccine Price by Application (2027-2032) & (USD/Dose) Table 69. North America Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 70. North America Human Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Europe Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 72. Europe Human Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Asia-Pacific Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 74. Asia-Pacific Human Vaccine Sales by Application (2021-2026) & (US$ Million) Table 75. Latin America Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 76. Latin America Human Vaccine Sales by Application (2021-2026) & (US$ Million) Table 77. Middle East and Africa Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 78. Middle East and Africa Human Vaccine Sales by Application (2021-2026) & (US$ Million) Table 79. CNBG Company Information Table 80. CNBG Business Overview Table 81. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 82. CNBG Human Vaccine Product Portfolio Table 83. CNBG Recent Development Table 84. Changsheng Life Company Information Table 85. Changsheng Life Business Overview Table 86. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 87. Changsheng Life Human Vaccine Product Portfolio Table 88. Changsheng Life Recent Development Table 89. Zhifei Company Information Table 90. Zhifei Business Overview Table 91. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 92. Zhifei Human Vaccine Product Portfolio Table 93. Zhifei Recent Development Table 94. ChengDa Bio Company Information Table 95. ChengDa Bio Business Overview Table 96. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 97. ChengDa Bio Human Vaccine Product Portfolio Table 98. ChengDa Bio Recent Development Table 99. Kangtai Company Information Table 100. Kangtai Business Overview Table 101. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 102. Kangtai Human Vaccine Product Portfolio Table 103. Kangtai Recent Development Table 104. SINOVAC BIOTECH Company Information Table 105. SINOVAC BIOTECH Business Overview Table 106. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 107. SINOVAC BIOTECH Human Vaccine Product Portfolio Table 108. SINOVAC BIOTECH Recent Development Table 109. Hissen Company Information Table 110. Hissen Business Overview Table 111. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 112. Hissen Human Vaccine Product Portfolio Table 113. Hissen Recent Development Table 114. Walvax Biotechnology Company Information Table 115. Walvax Biotechnology Business Overview Table 116. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 117. Walvax Biotechnology Human Vaccine Product Portfolio Table 118. Walvax Biotechnology Recent Development Table 119. GSK Company Information Table 120. GSK Business Overview Table 121. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 122. GSK Human Vaccine Product Portfolio Table 123. GSK Recent Development Table 124. SANOFI Company Information Table 125. SANOFI Business Overview Table 126. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 127. SANOFI Human Vaccine Product Portfolio Table 128. SANOFI Recent Development Table 129. Rong An Company Information Table 130. Rong An Business Overview Table 131. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 132. Rong An Human Vaccine Product Portfolio Table 133. Rong An Recent Development Table 134. NuoCheng Bio Company Information Table 135. NuoCheng Bio Business Overview Table 136. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 137. NuoCheng Bio Human Vaccine Product Portfolio Table 138. NuoCheng Bio Recent Development Table 139. Hualan Bio Company Information Table 140. Hualan Bio Business Overview Table 141. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 142. Hualan Bio Human Vaccine Product Portfolio Table 143. Hualan Bio Recent Development Table 144. Tiantan biological Company Information Table 145. Tiantan biological Business Overview Table 146. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 147. Tiantan biological Human Vaccine Product Portfolio Table 148. Tiantan biological Recent Development Table 149. Changchun Baike Company Information Table 150. Changchun Baike Business Overview Table 151. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 152. Changchun Baike Human Vaccine Product Portfolio Table 153. Changchun Baike Recent Development Table 154. Adimmune Company Information Table 155. Adimmune Business Overview Table 156. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 157. Adimmune Human Vaccine Product Portfolio Table 158. Adimmune Recent Development Table 159. Zhongyianke Biotech Company Information Table 160. Zhongyianke Biotech Business Overview Table 161. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 162. Zhongyianke Biotech Human Vaccine Product Portfolio Table 163. Zhongyianke Biotech Recent Development Table 164. Bharat Biotech Company Information Table 165. Bharat Biotech Business Overview Table 166. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 167. Bharat Biotech Human Vaccine Product Portfolio Table 168. Bharat Biotech Recent Development Table 169. Bavarian Nordic Company Information Table 170. Bavarian Nordic Business Overview Table 171. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 172. Bavarian Nordic Human Vaccine Product Portfolio Table 173. Bavarian Nordic Recent Development Table 174. Sanofi-Pasteur Company Information Table 175. Sanofi-Pasteur Business Overview Table 176. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 177. Sanofi-Pasteur Human Vaccine Product Portfolio Table 178. Sanofi-Pasteur Recent Development Table 179. Indian Immunologicals Company Information Table 180. Indian Immunologicals Business Overview Table 181. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 182. Indian Immunologicals Human Vaccine Product Portfolio Table 183. Indian Immunologicals Recent Development Table 184. KANGH Company Information Table 185. KANGH Business Overview Table 186. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 187. KANGH Human Vaccine Product Portfolio Table 188. KANGH Recent Development Table 189. Henan Grand Biopharma Company Information Table 190. Henan Grand Biopharma Business Overview Table 191. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 192. Henan Grand Biopharma Human Vaccine Product Portfolio Table 193. Henan Grand Biopharma Recent Development Table 194. ZhongKe Biopharm Company Information Table 195. ZhongKe Biopharm Business Overview Table 196. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 197. ZhongKe Biopharm Human Vaccine Product Portfolio Table 198. ZhongKe Biopharm Recent Development Table 199. Zhuoyi Biological Company Information Table 200. Zhuoyi Biological Business Overview Table 201. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 202. Zhuoyi Biological Human Vaccine Product Portfolio Table 203. Zhuoyi Biological Recent Development Table 204. North America Human Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 205. North America Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 206. North America Human Vaccine Sales Market Share by Country (2021-2026) Table 207. North America Human Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 208. North America Human Vaccine Sales Market Share Forecast by Country (2027-2032) Table 209. North America Human Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. North America Human Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 211. North America Human Vaccine Market Share by Country (2021-2026) Table 212. North America Human Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. North America Human Vaccine Market Share Forecast by Country (2027-2032) Table 214. Europe Human Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 215. Europe Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 216. Europe Human Vaccine Sales Market Share by Country (2021-2026) Table 217. Europe Human Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 218. Europe Human Vaccine Sales Market Share Forecast by Country (2027-2032) Table 219. Europe Human Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Europe Human Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 221. Europe Human Vaccine Market Share by Country (2021-2026) Table 222. Europe Human Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Europe Human Vaccine Market Share Forecast by Country (2027-2032) Table 224. Asia-Pacific Human Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 225. Asia-Pacific Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 226. Asia-Pacific Human Vaccine Sales Market Share by Country (2021-2026) Table 227. Asia-Pacific Human Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 228. Asia-Pacific Human Vaccine Sales Market Share Forecast by Country (2027-2032) Table 229. Asia-Pacific Human Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 230. Asia-Pacific Human Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 231. Asia-Pacific Human Vaccine Market Share by Country (2021-2026) Table 232. Asia-Pacific Human Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 233. Asia-Pacific Human Vaccine Market Share Forecast by Country (2027-2032) Table 234. Latin America Human Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 235. Latin America Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 236. Latin America Human Vaccine Sales Market Share by Country (2021-2026) Table 237. Latin America Human Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 238. Latin America Human Vaccine Sales Market Share Forecast by Country (2027-2032) Table 239. Latin America Human Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 240. Latin America Human Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 241. Latin America Human Vaccine Market Share by Country (2021-2026) Table 242. Latin America Human Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 243. Latin America Human Vaccine Market Share Forecast by Country (2027-2032) Table 244. Middle East and Africa Human Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 245. Middle East and Africa Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 246. Middle East and Africa Human Vaccine Sales Market Share by Country (2021-2026) Table 247. Middle East and Africa Human Vaccine Sales Forecast by Country (2027-2032) & (M Doses) Table 248. Middle East and Africa Human Vaccine Sales Market Share Forecast by Country (2027-2032) Table 249. Middle East and Africa Human Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 250. Middle East and Africa Human Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 251. Middle East and Africa Human Vaccine Market Share by Country (2021-2026) Table 252. Middle East and Africa Human Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 253. Middle East and Africa Human Vaccine Market Share Forecast by Country (2027-2032) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Human Vaccine Distributors List Table 257. Human Vaccine Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Human Vaccine Image Figure 2. Global Human Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Vaccine Sales (2021-2032) & (M Doses) Figure 5. Varicella Image Figure 6. Global Varicella Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Influenza Image Figure 8. Global Influenza Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Polio Image Figure 10. Global Polio Sales YoY Growth (2021-2032) & (M Doses) Figure 11. Hepatitis A Image Figure 12. Global Hepatitis A Sales YoY Growth (2021-2032) & (M Doses) Figure 13. Rabies Image Figure 14. Global Rabies Sales YoY Growth (2021-2032) & (M Doses) Figure 15. BCG Image Figure 16. Global BCG Sales YoY Growth (2021-2032) & (M Doses) Figure 17. Hepatitis B Image Figure 18. Global Hepatitis B Sales YoY Growth (2021-2032) & (M Doses) Figure 19. Pertussis, Diphtheria, Tetanus Image Figure 20. Global Pertussis, Diphtheria, Tetanus Sales YoY Growth (2021-2032) & (M Doses) Figure 21. Pneumococcal Image Figure 22. Global Pneumococcal Sales YoY Growth (2021-2032) & (M Doses) Figure 23. Rota vaccine Image Figure 24. Global Rota vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Global Human Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 26. Global Human Vaccine Market Share by Type 2025 VS 2032 Figure 27. North America Human Vaccine Sales Market Share in Volume by Type in 2025 Figure 28. North America Human Vaccine Sales Market Share in Value by Type in 2025 Figure 29. Europe Human Vaccine Sales Market Share in Volume by Type in 2025 Figure 30. Europe Human Vaccine Sales Market Share in Value by Type in 2025 Figure 31. Asia-Pacific Human Vaccine Sales Market Share in Volume by Type in 2025 Figure 32. Asia-Pacific Human Vaccine Sales Market Share in Value by Type in 2025 Figure 33. Latin America Human Vaccine Sales Market Share in Volume by Type in 2025 Figure 34. Latin America Human Vaccine Sales Market Share in Value by Type in 2025 Figure 35. Middle East and Africa Human Vaccine Sales Market Share in Volume by Type in 2025 Figure 36. Middle East and Africa Human Vaccine Sales Market Share in Value by Type in 2025 Figure 37. Global Top 5 and 10 Human Vaccine Players Market Share by Revenue in 2025 Figure 38. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 39. Adults Image Figure 40. Global Adults Sales YoY Growth (2021-2032) & (M Doses) Figure 41. Children Image Figure 42. Global Children Sales YoY Growth (2021-2032) & (M Doses) Figure 43. Global Human Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Human Vaccine Market Share by Application 2025 VS 2032 Figure 45. North America Human Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. North America Human Vaccine Sales Market Share in Value by Application in 2025 Figure 47. Europe Human Vaccine Sales Market Share in Volume by Application in 2025 Figure 48. Europe Human Vaccine Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Human Vaccine Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Human Vaccine Sales Market Share in Value by Application in 2025 Figure 51. Latin America Human Vaccine Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Human Vaccine Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Human Vaccine Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Human Vaccine Sales Market Share in Value by Application in 2025 Figure 55. North America Human Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. North America Human Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Human Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Human Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Human Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 60. Europe Human Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Human Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Human Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Human Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 64. Asia-Pacific Human Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Human Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Human Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Human Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 68. Latin America Human Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Human Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Human Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Human Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 72. Middle East and Africa Human Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Human Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Human Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Human Vaccine Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Human Vaccine Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine
Applications
  • Adults
  • Children
Companies covered
  • CNBG
  • Changsheng Life
  • Zhifei
  • ChengDa Bio
  • Kangtai
  • SINOVAC BIOTECH
  • Hissen
  • Walvax Biotechnology
  • GSK
  • SANOFI
  • Rong An
  • NuoCheng Bio
  • Hualan Bio
  • Tiantan biological
  • Changchun Baike
  • Adimmune
  • Zhongyianke Biotech
  • Bharat Biotech
  • Bavarian Nordic
  • Sanofi-Pasteur
  • Indian Immunologicals
  • KANGH
  • Henan Grand Biopharma
  • ZhongKe Biopharm
  • Zhuoyi Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Vaccine Market by Type
  6. 1.3.1 Varicella
  7. 1.3.2 Influenza
  8. 1.3.3 Polio
  9. 1.3.4 Hepatitis A
  10. 1.3.5 Rabies
  11. 1.3.6 BCG
  12. 1.3.7 Hepatitis B
  13. 1.3.8 Pertussis, Diphtheria, Tetanus
  14. 1.3.9 Pneumococcal
  15. 1.3.10 Rota vaccine
  16. 1.4 Global Human Vaccine Market Size by Type
  17. 1.4.1 Global Human Vaccine Market Size Overview by Type (2021-2032)
  18. 1.4.2 Global Human Vaccine Historic Market Size Review by Type (2021-2026)
  19. 1.4.3 Global Human Vaccine Forecasted Market Size by Type (2027-2032)
  20. 1.5 Key Regions Market Size by Type
  21. 1.5.1 North America Human Vaccine Sales Breakdown by Type (2021-2026)
  22. 1.5.2 Europe Human Vaccine Sales Breakdown by Type (2021-2026)
  23. 1.5.3 Asia-Pacific Human Vaccine Sales Breakdown by Type (2021-2026)
  24. 1.5.4 South America Human Vaccine Sales Breakdown by Type (2021-2026)
  25. 1.5.5 Middle East and Africa Human Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Vaccine Industry Trends
  2. 2.2 Human Vaccine Industry Drivers
  3. 2.3 Human Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Human Vaccine Price (2021-2026)
  4. 3.4 Global Human Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Human Vaccine Company, Product Type & Application
  7. 3.7 Global Human Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Vaccine Tier 1, Tier 2, and Tier 3
4 Human Vaccine Regional Status and Outlook
  1. 4.1 Global Human Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Vaccine Historic Market Size by Region
  3. 4.2.1 Global Human Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Human Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Vaccine by Application
  1. 5.1 Human Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Human Vaccine Market Size by Application
  5. 5.2.1 Global Human Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CNBG
  2. 6.1.1 CNBG Company Information
  3. 6.1.2 CNBG Business Overview
  4. 6.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CNBG Human Vaccine Product Portfolio
  6. 6.1.5 CNBG Recent Developments
  7. 6.2 Changsheng Life
  8. 6.2.1 Changsheng Life Company Information
  9. 6.2.2 Changsheng Life Business Overview
  10. 6.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Changsheng Life Human Vaccine Product Portfolio
  12. 6.2.5 Changsheng Life Recent Developments
  13. 6.3 Zhifei
  14. 6.3.1 Zhifei Company Information
  15. 6.3.2 Zhifei Business Overview
  16. 6.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhifei Human Vaccine Product Portfolio
  18. 6.3.5 Zhifei Recent Developments
  19. 6.4 ChengDa Bio
  20. 6.4.1 ChengDa Bio Company Information
  21. 6.4.2 ChengDa Bio Business Overview
  22. 6.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ChengDa Bio Human Vaccine Product Portfolio
  24. 6.4.5 ChengDa Bio Recent Developments
  25. 6.5 Kangtai
  26. 6.5.1 Kangtai Company Information
  27. 6.5.2 Kangtai Business Overview
  28. 6.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kangtai Human Vaccine Product Portfolio
  30. 6.5.5 Kangtai Recent Developments
  31. 6.6 SINOVAC BIOTECH
  32. 6.6.1 SINOVAC BIOTECH Company Information
  33. 6.6.2 SINOVAC BIOTECH Business Overview
  34. 6.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
  36. 6.6.5 SINOVAC BIOTECH Recent Developments
  37. 6.7 Hissen
  38. 6.7.1 Hissen Company Information
  39. 6.7.2 Hissen Business Overview
  40. 6.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hissen Human Vaccine Product Portfolio
  42. 6.7.5 Hissen Recent Developments
  43. 6.8 Walvax Biotechnology
  44. 6.8.1 Walvax Biotechnology Company Information
  45. 6.8.2 Walvax Biotechnology Business Overview
  46. 6.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
  48. 6.8.5 Walvax Biotechnology Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK Human Vaccine Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 SANOFI
  56. 6.10.1 SANOFI Company Information
  57. 6.10.2 SANOFI Business Overview
  58. 6.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SANOFI Human Vaccine Product Portfolio
  60. 6.10.5 SANOFI Recent Developments
  61. 6.11 Rong An
  62. 6.11.1 Rong An Company Information
  63. 6.11.2 Rong An Business Overview
  64. 6.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Rong An Human Vaccine Product Portfolio
  66. 6.11.5 Rong An Recent Developments
  67. 6.12 NuoCheng Bio
  68. 6.12.1 NuoCheng Bio Company Information
  69. 6.12.2 NuoCheng Bio Business Overview
  70. 6.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 NuoCheng Bio Human Vaccine Product Portfolio
  72. 6.12.5 NuoCheng Bio Recent Developments
  73. 6.13 Hualan Bio
  74. 6.13.1 Hualan Bio Company Information
  75. 6.13.2 Hualan Bio Business Overview
  76. 6.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hualan Bio Human Vaccine Product Portfolio
  78. 6.13.5 Hualan Bio Recent Developments
  79. 6.14 Tiantan biological
  80. 6.14.1 Tiantan biological Company Information
  81. 6.14.2 Tiantan biological Business Overview
  82. 6.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Tiantan biological Human Vaccine Product Portfolio
  84. 6.14.5 Tiantan biological Recent Developments
  85. 6.15 Changchun Baike
  86. 6.15.1 Changchun Baike Company Information
  87. 6.15.2 Changchun Baike Business Overview
  88. 6.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Changchun Baike Human Vaccine Product Portfolio
  90. 6.15.5 Changchun Baike Recent Developments
  91. 6.16 Adimmune
  92. 6.16.1 Adimmune Company Information
  93. 6.16.2 Adimmune Business Overview
  94. 6.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Adimmune Human Vaccine Product Portfolio
  96. 6.16.5 Adimmune Recent Developments
  97. 6.17 Zhongyianke Biotech
  98. 6.17.1 Zhongyianke Biotech Company Information
  99. 6.17.2 Zhongyianke Biotech Business Overview
  100. 6.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
  102. 6.17.5 Zhongyianke Biotech Recent Developments
  103. 6.18 Bharat Biotech
  104. 6.18.1 Bharat Biotech Company Information
  105. 6.18.2 Bharat Biotech Business Overview
  106. 6.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bharat Biotech Human Vaccine Product Portfolio
  108. 6.18.5 Bharat Biotech Recent Developments
  109. 6.19 Bavarian Nordic
  110. 6.19.1 Bavarian Nordic Company Information
  111. 6.19.2 Bavarian Nordic Business Overview
  112. 6.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Bavarian Nordic Human Vaccine Product Portfolio
  114. 6.19.5 Bavarian Nordic Recent Developments
  115. 6.20 Sanofi-Pasteur
  116. 6.20.1 Sanofi-Pasteur Company Information
  117. 6.20.2 Sanofi-Pasteur Business Overview
  118. 6.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
  120. 6.20.5 Sanofi-Pasteur Recent Developments
  121. 6.21 Indian Immunologicals
  122. 6.21.1 Indian Immunologicals Company Information
  123. 6.21.2 Indian Immunologicals Business Overview
  124. 6.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Indian Immunologicals Human Vaccine Product Portfolio
  126. 6.21.5 Indian Immunologicals Recent Developments
  127. 6.22 KANGH
  128. 6.22.1 KANGH Company Information
  129. 6.22.2 KANGH Business Overview
  130. 6.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 KANGH Human Vaccine Product Portfolio
  132. 6.22.5 KANGH Recent Developments
  133. 6.23 Henan Grand Biopharma
  134. 6.23.1 Henan Grand Biopharma Company Information
  135. 6.23.2 Henan Grand Biopharma Business Overview
  136. 6.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
  138. 6.23.5 Henan Grand Biopharma Recent Developments
  139. 6.24 ZhongKe Biopharm
  140. 6.24.1 ZhongKe Biopharm Company Information
  141. 6.24.2 ZhongKe Biopharm Business Overview
  142. 6.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
  144. 6.24.5 ZhongKe Biopharm Recent Developments
  145. 6.25 Zhuoyi Biological
  146. 6.25.1 Zhuoyi Biological Company Information
  147. 6.25.2 Zhuoyi Biological Business Overview
  148. 6.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
  150. 6.25.5 Zhuoyi Biological Recent Developments
7 North America by Country
  1. 7.1 North America Human Vaccine Sales by Country
  2. 7.1.1 North America Human Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Human Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Vaccine Market Size by Country
  6. 7.2.1 North America Human Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Vaccine Sales by Country
  2. 8.1.1 Europe Human Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Vaccine Market Size by Country
  6. 8.2.1 Europe Human Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Human Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Human Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Vaccine Sales by Country
  2. 10.1.1 South America Human Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Human Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Vaccine Market Size by Country
  6. 10.2.1 South America Human Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Human Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Human Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Vaccine Value Chain Analysis
  2. 12.1.1 Human Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Vaccine Production Mode & Process
  7. 12.2 Human Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Vaccine Distributors
  10. 12.2.3 Human Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst